RETINITIS PIGMENTOSA
Clinical trials for RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental eye drug shows promise for rare Blindness-Causing disease
Disease control CompletedThis early-phase study tested an experimental drug called ADX-2191 in 8 adults with retinitis pigmentosa caused by a specific gene mutation (rhodopsin). Participants received multiple injections into the worse-seeing eye to evaluate safety and any changes in vision. The goal was …
Matched conditions: RETINITIS PIGMENTOSA
Phase: PHASE2 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 10:28 UTC
-
Experimental eye injection aims to restore sight in rare blindness conditions
Disease control CompletedThis study tested a new drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two rare diseases that cause progressive vision loss. The main goal was to check the treatment's safety and tolerability, while also looking at…
Matched conditions: RETINITIS PIGMENTOSA
Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Thousands donate DNA to unlock secrets of rare eye diseases
Knowledge-focused CompletedThis study created a national DNA and blood bank for inherited eye diseases like retinitis pigmentosa. Over 6,600 participants provided blood samples and had standard eye exams. The goal was to help researchers identify genetic causes and speed up the development of new treatment…
Matched conditions: RETINITIS PIGMENTOSA
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated May 17, 2026 10:28 UTC
-
Eye tests under the microscope for blinding disease
Knowledge-focused CompletedThis study looked at how well different eye exams can measure changes in retinitis pigmentosa (RP), a group of eye diseases that cause blindness. Researchers tested 49 people with RP and healthy volunteers using several vision tests, repeating them about six weeks later to see ho…
Matched conditions: RETINITIS PIGMENTOSA
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated May 17, 2026 10:26 UTC